InvestorsHub Logo
Followers 2
Posts 385
Boards Moderated 0
Alias Born 09/20/2017

Re: None

Friday, 10/05/2018 9:41:24 PM

Friday, October 05, 2018 9:41:24 PM

Post# of 3987
It seems that Protalix is aiming at the NASH market. Would be very grateful if anyone can explain this presentation .

Gut-based immunotherapy - implications for NASH
Targeting the gut immune system for alleviation of the systemic
inflammatory response without immune suppression
Yaron Ilan, M.D.
Gastroenterology and Liver Units, Department of Medicine
Hebrew University-Hadassah Medical Center
Jerusalem, Israel

https://paris-nash.org/data-2018/NASH-2018-ILAN-Y.pdf
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PLX News